Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Efficiency of different control measures for preventing carbapenemase-producing enterobacteria and glycopeptide-resistant Enterococcus faecium outbreaks: a 6-year prospective study in a French multihospital institution, January 2010 to December 2015.

Fournier S, Desenfant L, Monteil C, Nion-Huang M, Richard C, Jarlier V; The Ap-Hp Outbreaks Control Group.

Euro Surveill. 2018 Feb;23(8). doi: 10.2807/1560-7917.ES.2018.23.8.17-00078.

2.

Vaccine coverage of healthcare students in hospitals of the Paris region in 2009: the Studyvax survey.

Loulergue P, Fonteneau L, Armengaud JB, Momcilovic S, Levy-Brühl D, Launay O, Guthmann JP; Studyvax survey group.

Vaccine. 2013 Jun 10;31(26):2835-8. doi: 10.1016/j.vaccine.2013.04.004. Epub 2013 Apr 24.

PMID:
23623864
3.

Twenty years of antimicrobial resistance control programme in a regional multi hospital institution, with focus on emerging bacteria (VRE and CPE).

Fournier S, Brun-Buisson C, Jarlier V.

Antimicrob Resist Infect Control. 2012 Feb 13;1(1):9. doi: 10.1186/2047-2994-1-9.

4.

Link between carbapenemase-producing Enterobacteria carriage and cross-border exchanges: eight-year surveillance in a large French multihospitals institution.

Fournier S, Lepainteur M, Kassis-Chikhani N, Huang M, Brun-Buisson C, Jarlier V; AP-HP Outbreaks Control Group.

J Travel Med. 2012 Sep-Oct;19(5):320-3. doi: 10.1111/j.1708-8305.2012.00641.x. Epub 2012 Aug 1.

5.

[Alliance against MDRO: safeguarding antibiotics].

Carlet J, Rambaud C, Pulcini C; l'Alliance contre développement des bactéries multirésistantes (ACdeBMR).

Ann Fr Anesth Reanim. 2012 Sep;31(9):704-8. doi: 10.1016/j.annfar.2012.07.003. Epub 2012 Aug 24. French.

PMID:
22925945
6.

Risk of highly resistant bacteria importation from repatriates and travelers hospitalized in foreign countries: about the French recommendations to limit their spread.

Lepelletier D, Andremont A, Grandbastien B; National Working Group.

J Travel Med. 2011 Sep-Oct;18(5):344-51. doi: 10.1111/j.1708-8305.2011.00547.x. Epub 2011 Aug 15. Review. No abstract available.

7.

[Stop bacterial resistance: save antibiotics].

Carlet J; le groupe Alliance francophone contre le développement des bactéries multi-résistantes aux antibiotiques (AC-2-BMR).

Med Mal Infect. 2011 Jul;41(7):351-2. doi: 10.1016/j.medmal.2011.06.003. Epub 2011 Jul 20. French. No abstract available.

PMID:
21764235
8.

Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program.

Jarlier V, Trystram D, Brun-Buisson C, Fournier S, Carbonne A, Marty L, Andremont A, Arlet G, Buu-Hoi A, Carlet J, Decré D, Gottot S, Gutmann L, Joly-Guillou ML, Legrand P, Nicolas-Chanoine MH, Soussy CJ, Wolf M, Lucet JC, Aggoune M, Brücker G, Régnier B; Collégiale de Bactériologie-Virologie-Hygiène des Hôpitaux Universitaires de l'Ile de France.

Arch Intern Med. 2010 Mar 22;170(6):552-9. doi: 10.1001/archinternmed.2010.32.

PMID:
20308642
9.

[Treatment interruption in 30 HIV-infected patients with successful viral suppression under highly active antiretroviral treatment].

Pavie J, Porcher R, Fournier S, André F, Tournoux C, Palmer P, Rabian C, Jean-Michel M.

Presse Med. 2005 Jun 4;34(10 Suppl):1S8-13. French.

PMID:
16025661
10.

Simplification therapy with once-daily emtricitabine, didanosine, and efavirenz in HIV-1-infected adults with viral suppression receiving a protease inhibitor-based regimen: a randomized trial.

Molina JM, Journot V, Morand-Joubert L, Yéni P, Rozenbaum W, Rancinan C, Fournier S, Morlat P, Palmer P, Dupont B, Goujard C, Dellamonica P, Collin F, Poizot-Martin I, Chene G; ALIZE (Agence Nationale de Recherches sur le SIDA 099) Study Team.

J Infect Dis. 2005 Mar 15;191(6):830-9. Epub 2005 Feb 10.

PMID:
15717256
12.

Detection of Microsporidia, cryptosporidia and Giardia in swimming pools: a one-year prospective study.

Fournier S, Dubrou S, Liguory O, Gaussin F, Santillana-Hayat M, Sarfati C, Molina JM, Derouin F.

FEMS Immunol Med Microbiol. 2002 Jul 12;33(3):209-13.

13.

Effects of chemical and physical agents on viability and infectivity of Encephalitozoon intestinalis determined by cell culture and flow cytometry.

Santillana-Hayat M, Sarfati C, Fournier S, Chau F, Porcher R, Molina JM, Derouin F.

Antimicrob Agents Chemother. 2002 Jun;46(6):2049-51.

Supplemental Content

Loading ...
Support Center